Where Healthcare Meets Growth
Your Partner for Accelerated Business Transformation
Sheridan is a healthcare-focused private equity firm, bringing sector knowledge with a collaborative and strategic approach to building enduring value.
Raised
Platforms
Add-ons
Organic growth achieved vs. industry average
As of September 30, 2024
The Sheridan Foundation is Built Upon
a Lasting Commitment to Our Partners
Sheridan strives to build enduring value by providing growth-oriented solutions across the healthcare landscape.
Engaged, Thesis-Driven Investors
Utilizing a disciplined and focused approach, we seek to partner with founders and management teams in select healthcare subsectors, leveraging our deep connections and extensive resources to help them grow and optimize their operations for the benefit of patients, clients, and shareholders alike.
Helping Build Exceptional
Healthcare Companies
We empower our partners to achieve their goals and meaningfully scale their companies.
Sheridan helped us grow well beyond our expectations, but they were equally thoughtful about knowing when and how to find the right partner for the next phase of our journey.
Scotte Hudsmith CEO & Chairman | Smile Doctors
We could not be more pleased with the outcome of our partnership with Sheridan. Since the very beginning, the Sheridan team invested in our organization and our people to advance our mission of helping hospitals improve patient care through the delivery of our innovative cost-savings solutions.
Dan Geelhoed CEO & Co-Founder | SpendMend
Our company operates within a highly nuanced framework of agency oversight. Sheridan understood this landscape better than any other group and was able to move quickly and decisively to close our deal.
Michael Blaire CEO & Founder | Diamondback Drugs
Sheridan helped us grow well beyond our expectations, but they were equally thoughtful about knowing when and how to find the right partner for the next phase of our journey.
Scotte Hudsmith CEO & Chairman | Smile Doctors
We could not be more pleased with the outcome of our partnership with Sheridan. Since the very beginning, the Sheridan team invested in our organization and our people to advance our mission of helping hospitals improve patient care through the delivery of our innovative cost-savings solutions.
Dan Geelhoed CEO & Co-Founder | SpendMend
Our company operates within a highly nuanced framework of agency oversight. Sheridan understood this landscape better than any other group and was able to move quickly and decisively to close our deal.
Michael Blaire CEO & Founder | Diamondback Drugs
Committed, Capable, and Friendly Partners
Sheridan’s reputation is founded on working collaboratively as we provide access to our extensive healthcare expertise and network. We pride ourselves on the long-term relationships we build with our partners.
Follow Our Progress
Explore the latest news about our investment activity and portfolio companies.
CHICAGO, IL – May 28, 2025 – Sheridan Capital Partners (“Sheridan”) today announced the majority sale of DAS Health Ventures, LLC (“DAS Health” or “the Company”), a provider of healthcare IT and business solutions, to Coalesce Capital. Sheridan initially partnered with DAS Health in 2021 and will retain a minority ownership position following the transaction.
CHICAGO, IL – May 9, 2025 – Sheridan Capital Partners (“SCP”) partnered with FirstEnroll (now branded as Heathos), a health insurance billing and enrollment third-party administrator (“TPA”) providing independent agencies and agents administrative support for supplemental health insurance products, in June 2023.
CHICAGO, IL – April 8, 2025 – Sheridan Capital Partners (“SCP”) partnered with Future Care Consultants (“FCC”, now branded as Focal Point Care “FPC”), a specialty revenue cycle management and technology-enabled back-office outsourced services provider to the skilled nursing facility (“SNF”) market, in January 2023.